Literature DB >> 15380574

Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.

Rodney J Hicks1, Michael P Mac Manus, Jane P Matthews, Annette Hogg, David Binns, Danny Rischin, David L Ball, Lester J Peters.   

Abstract

PURPOSE: To investigate the relationship between positron emission tomography (PET) detected inflammatory changes in irradiated normal tissues and metabolic response at tumor sites in patients receiving radical radiotherapy for non-small-cell lung cancer. The prognostic significance of these changes was also studied.
METHODS: In 73 consecutive patients, (18)F-fluorodeoxyglucose (FDG) PET was performed at a median of 70 days after completion of radical radiotherapy. Radiation-induced inflammatory change was scored for normal tissues within the radiation treatment volume using a 0-3 grading scale. Metabolic tumor response was assessed using a pattern-recognition algorithm comparing pre- and posttreatment scans. Prognostic significance of inflammatory changes was tested using the Cox proportional hazards regression model.
RESULTS: Increased FDG uptake in normal tissues (radiotoxicity) was associated with a greater likelihood of complete or partial tumor response on both PET (p = 0.0044) and computed tomography (p = 0.029). Prognostic stratification provided by PET response was both significant and of a similar magnitude in patients with low- and high-grade radiotoxicity.
CONCLUSION: Postradiotherapy inflammatory changes detected by FDG-PET are positively correlated with tumor response, suggesting that tumor radioresponsiveness and normal tissue radiosensitivity may be linked. Prognostic stratification provided by PET is not compromised by inflammatory changes if a meticulous visual response assessment technique is used.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380574     DOI: 10.1016/j.ijrobp.2004.03.036

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  48 in total

Review 1.  Imaging radiation response in tumor and normal tissue.

Authors:  Marjan Rafat; Rehan Ali; Edward E Graves
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

Review 2.  Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.

Authors:  P M Price; M M Green
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

3.  ¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.

Authors:  Shankar Siva; Siddhartha Deb; Richard J Young; Rodney J Hicks; Jason Callahan; Mathias Bressel; Linda Mileshkin; Danny Rischin; David Bernshaw; Kailash Narayan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-15       Impact factor: 9.236

Review 4.  Monitoring chemotherapy and radiotherapy of solid tumors.

Authors:  Wolfgang A Weber; Hinrich Wieder
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

Review 5.  The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning.

Authors:  S Alobaidli; S McQuaid; C South; V Prakash; P Evans; A Nisbet
Journal:  Br J Radiol       Date:  2014-07-23       Impact factor: 3.039

Review 6.  Imaging radiation-induced normal tissue injury.

Authors:  Mike E Robbins; Judy K Brunso-Bechtold; Ann M Peiffer; Christina I Tsien; Janet E Bailey; Lawrence B Marks
Journal:  Radiat Res       Date:  2012-02-21       Impact factor: 2.841

Review 7.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

8.  Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.

Authors:  Jinbo Yue; Qiuling Shi; Ting Xu; Melenda Jeter; Ting-Yu Chen; Ritsuko Komaki; Daniel R Gomez; Tinsu Pan; Charles S Cleeland; Zhongxing Liao; Xin Shelley Wang
Journal:  Qual Life Res       Date:  2018-03-16       Impact factor: 4.147

9.  Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy.

Authors:  Ken Dornfeld; Shane Hopkins; Joel Simmons; Douglas R Spitz; Yusuf Menda; Michael Graham; Russell Smith; Gerry Funk; Lucy Karnell; Michael Karnell; Maude Dornfeld; Min Yao; John Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

10.  Positron emission tomography in the management of lung cancer.

Authors:  Vahid Reza Dabbagh Kakhki
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.